ValiRx (STU:EAJF) 5-Year Share Buyback Ratio : -86.00% (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ValiRx 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. ValiRx's current 5-Year Share Buyback Ratio was -86.00%.

STU:EAJF's 5-Year Share Buyback Ratio is ranked worse than
94.83% of 1160 companies
in the Biotechnology industry
Industry Median: -12.1 vs STU:EAJF: -86.00

Competitive Comparison of ValiRx's 5-Year Share Buyback Ratio

For the Biotechnology subindustry, ValiRx's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ValiRx's 5-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ValiRx's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where ValiRx's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

ValiRx 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

ValiRx (STU:EAJF) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

ValiRx 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of ValiRx's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ValiRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (STU:EAJF) » Definitions » 5-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

VAL:UK EAJF:Germany

Address

D6 Thane Road, MediCity Nottingham, Nottingham, GBR, NG90 6BH

Website

https://www.valirx.com

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, VAL401 for lung cancer, VAL301, BC201, CLX001, and other drug candidates in their different stages of development.

ValiRx Headlines

No Headlines